INDGN logo

Indegene Limited Stock Price

NSEI:INDGN Community·₹139.1b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 12 Fair Values set on narratives written by author
Create a narrative

INDGN Share Price Performance

₹579.75
-106.25 (-15.49%)
10.1% undervalued intrinsic discount
₹644.67
Fair Value
₹579.75
-106.25 (-15.49%)
10.0% undervalued intrinsic discount
₹644.39
Fair Value
Price ₹579.75
AnalystConsensusTarget ₹644.39

INDGN Community Narratives

AnalystConsensusTarget·Updated
Fair Value ₹644.67 10.1% undervalued intrinsic discount

Digital Transformation And AI Adoption Will Expand Pharma Market

0users have liked this narrative
0users have commented on this narrative
7users have followed this narrative

Recent INDGN News & Updates

Getting In Cheap On Indegene Limited (NSE:INDGN) Is Unlikely

Jul 23
Getting In Cheap On Indegene Limited (NSE:INDGN) Is Unlikely
User avatar

M&A And Cortex Integration Will Expand Enterprise Opportunities

M&A activities and AI integration signal innovation and efficiency, likely boosting topline growth and improving net margins through cost reductions.

Indegene Limited (NSE:INDGN) Annual Results: Here's What Analysts Are Forecasting For This Year

May 03
Indegene Limited (NSE:INDGN) Annual Results: Here's What Analysts Are Forecasting For This Year

Indegene Limited's (NSE:INDGN) Price Is Out Of Tune With Earnings

Feb 25
Indegene Limited's (NSE:INDGN) Price Is Out Of Tune With Earnings

Indegene Limited Key Details

₹29.2b

Revenue

₹624.0m

Cost of Revenue

₹28.6b

Gross Profit

₹24.3b

Other Expenses

₹4.4b

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
18.14
Gross Margin
97.87%
Net Profit Margin
14.89%
Debt/Equity Ratio
3.9%

Indegene Limited Competitors

 
 
 
 
 
 
 
 
 
 
 
 
View more competitors

Snowflake Analysis

Flawless balance sheet with solid track record.

0 Risks
4 Rewards
View Full Analysis

About INDGN

Founded
1998
Employees
4158
CEO
Manish Gupta
WebsiteView website
www.indegene.com

Indegene Limited operates as a digital-first life sciences commercialization company in India, the United States, Europe, and internationally. It operates through three segments: Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation & Others. The company develops biotech and medical device for biopharmaceutical, emerging biotech, and medical device companies. It also offers enterprise commercial, medical, and clinical solutions; and omnichannel activation solutions. In addition, the company operates NEXT technology platforms. Further, it provides analytics, technology, commercial, medical, regulatory, and safety services to life science and healthcare organizations. Indegene Limited was incorporated in 1998 and is based in Bengaluru, India.

Market Insight

Header cover image

✨Rare Earths: Tiny Market, Outsized Influence

Richard Bowman avatarRichard Bowman
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
Last Week
⚡ Utilities: Defensive Dividends Meet the AI Power Surge

⚡ Utilities: Defensive Dividends Meet the AI Power Surge

Indian Market Performance

  • 7 Days: 1.5%
  • 3 Months: -1.7%
  • 1 Year: -4.7%
  • Year to Date: 0.7%
Over the last 7 days, the market has risen 1.5%, driven by gains of 2.3% in the Financials sector. Longer term the market is actually down 4.7% over the past year. Looking forward, earnings are forecast to grow by 16% annually. Market details ›